|1.||Reichle, Albrecht: 4 articles (01/2011 - 11/2003)|
|2.||Vogt, Thomas: 3 articles (12/2004 - 11/2003)|
|3.||Thiel, Eckhard: 2 articles (06/2009 - 09/2004)|
|4.||Fischer, Lars: 2 articles (06/2009 - 09/2004)|
|5.||Jahnke, Kristoph: 2 articles (06/2009 - 09/2004)|
|6.||Bechrakis, Nikolaos E: 2 articles (06/2009 - 09/2004)|
|7.||Korfel, Agnieszka: 2 articles (06/2009 - 09/2004)|
|8.||Wagner, T: 2 articles (10/2006 - 12/2005)|
|9.||Landthaler, Michael: 2 articles (12/2004 - 11/2003)|
|10.||Hafner, Christian: 2 articles (12/2004 - 11/2003)|
03/01/2003 - "Trofosfamide, an alkylating agent, has been shown to be effective in several solid and haematological tumors. "
04/01/2007 - "Due to tumor progression after 2 cycles, she was switched to oral trofosfamide (150 mg daily). "
12/01/2004 - "However, the optimal dose of trofosfamide for patients with advanced cancer has not been systematically investigated yet. "
07/01/2004 - "We report herein a case of a 83-year-old female patient with a disseminated malignant peripheral nerve sheath tumor treated with trofosfamide developing pulmonal toxicity. "
06/01/1997 - "Trofosfamide: a review of its pharmacodynamic and pharmacokinetic properties and therapeutic potential in the oral treatment of cancer."
|2.||Non-Hodgkin Lymphoma (Lymphosarcoma)
01/01/1994 - "Complete remission after repeated trofosfamide treatment in relapsing high-grade malignant non-Hodgkin's lymphoma--a case report."
12/01/1995 - "Trofosfamide is effective in refractory non-Hodgkin's lymphoma."
01/01/1991 - "Twenty-three patients (12 females, 11 males) with malignant non-Hodgkin's lymphoma were treated with oral trofosfamide 50 mg t.i.d. "
01/01/1991 - "Trofosfamide in non-Hodgkin's lymphoma. "
12/01/2002 - "A few studies have shown that trofosfamide, an oral alkylating agent, may be effective as palliative treatment in non-Hodgkin's lymphoma. "
|3.||Sarcoma (Soft Tissue Sarcoma)
03/01/2003 - "No objective remission was observed with oral low-dose trofosfamide in heavily pretreated soft tissue sarcoma patients, but almost half of the patients achieved disease stabilisation for half a year. "
03/01/2003 - "Phase II trial of trofosfamide in patients with advanced pretreated soft tissue sarcomas."
12/01/2002 - "Oral trofosfamide: an active and well-tolerated maintenance therapy for adult patients with advanced bone and soft tissue sarcomas. "
01/01/1995 - "Oral trofosfamide: an active drug in the treatment of soft-tissue sarcoma."
03/01/2003 - "The moderate toxicity profile observed in this study allows the consideration of trofosfamide as a reasonable palliative treatment option for patients with soft tissue sarcoma."
|4.||Prostatic Neoplasms (Prostate Cancer)
01/01/2006 - "Palliative chemotherapy with trofosfamide in advanced prostate cancer."
01/01/2010 - "Here, we report a long-term remission over one year in a 68-year-old patient with metastatic docetaxel-refractory prostate cancer employing low-dose trofosfamide. "
01/01/2010 - "Metronomic treatment with low-dose trofosfamide leads to a long-term remission in a patient with docetaxel-refractory advanced metastatic prostate cancer."
01/01/2006 - "A phase II study with trofosfamide in hormone-refractory prostate cancer was conducted to test the palliative efficacy. "
01/01/2006 - "Trofosfamide has some activity in hormone-refractory advanced prostate cancer. "
09/01/2004 - "Treatment of primary intraocular lymphoma with oral trofosfamide: report of two cases and review of the literature."
03/01/1997 - "Trofosfamide as a salvage treatment with low toxicity in malignant lymphoma. "
01/01/1979 - "[Ixoten therapy in malignant lymphomas]."
03/01/1997 - "Trofosfamide is an interesting and a non-toxic palliative treatment for relapsing malignant lymphomas especially in elderly patients."
03/01/1997 - "37 patients with disease progression after prior treatment for malignant lymphoma (27 low grade, 7 high grade and 3 Hodgkin's) were treated with oral trofosfamide daily. "
|3.||Etoposide (VP 16)
|1.||Drug Therapy (Chemotherapy)
|2.||Palliative Care (Palliative Medicine)
|3.||Heterologous Transplantation (Xenotransplantation)